Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Biodesix has reported Amortization of Deferred Charges for 3 years, with the latest figure at $41000.0 in Q1 2021.

• For the quarter ending Q1 2021, Amortization of Deferred Charges rose 13.89% year-over-year to $41000.0; the trailing twelve-month figure through Mar 2021 stood at $147000.0 (changed N/A YoY), and the FY2020 full-year result was $144000.0, changed 0.0% from the prior year.
• Amortization of Deferred Charges for Q1 2021 stood at $41000.0, up from $35000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $41000.0 in Q1 2021, with the low at $35000.0 in Q4 2019.
• Historically, Amortization of Deferred Charges has averaged $36750.0 across 3 years, with a median of $35500.0 in 2019.
• Annual changes were most pronounced in 2020 — Amortization of Deferred Charges changed 0.0% — and 2021, when it climbed 13.89%.
• Biodesix's Amortization of Deferred Charges stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then rose by 17.14% to $41000.0 in 2021.
• The last three Amortization of Deferred Charges figures came in at $41000.0 (Q1 2021), $35000.0 (Q4 2020), and $36000.0 (Q1 2020), per Business Quant data.